Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL

Kedudukan dalam Saham #17814
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Harga Saham
$10.22
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$212.97M
Perubahan (1 hari)
4.58%
Perubahan (1 tahun)
2,278.10%
Negara
CA
Perdagangan Satellos Bioscience Inc. (MSCL)

Kategori

Healthcare
Sejarah pecahan saham untuk Satellos Bioscience Inc. (MSCL)
Saham Satellos Bioscience Inc. (simbol: MSCL) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham MSCL yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham MSCL.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL